Timolol 0.5% versus Latanoprost 0.005% as A Single Hypotensive Drug in Glaucoma Patients: A 2-year Follow-up
Background: Glaucoma is a progressive optic nerve disease that, despite its treatment, is associated with retinal ganglion cell damage. However, timely treatment hinders the progression of visual field damage and preserves visual function. Our study aimed to evaluate the treatment outcomes and adver...
| Published in: | International Journal of Biomedicine |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
International Medical Research and Development Corporation
2024-12-01
|
| Subjects: | |
| Online Access: | http://www.ijbm.org/articles/i56/ijbm_14(4)_oa15.pdf |
